Sep 29, 2020
The advent of biomarker testing has brought targeted cancer treatment to more patients than ever before. However, these tests require a collaborative effort from a number of specialists—and that means a high price tag. Additionally, private payers have different reimbursement structures that change...
Sep 8, 2020
The gender gap in healthcare leadership is well documented. In the oncology discipline, the divide is even wider—according to a recent survey, less than half of academic medical oncology programs have a woman in a leadership position, and that number decreases further for radiation and surgical oncology programs.
On...